APOE4 Exacerbates Cerebral Tau Pathology Through Cholesterol‐Induced Degradation of Phosphatase in Atherosclerosis
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70536 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Jiuyang Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Forensic Medicine, Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Apolipoprotein E4, Cholesterol, tau Proteins, Atherosclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Education of Guizhou Province, Guizhou Provincial Science and Technology Projects, Science Innovation 2030 - Brain Science and Brain-Inspired Intelligence Technology Major Project.
Abstract (Originalsprache)
Background
Apolipoprotein epsilon4 allele (APOE4) is a common risk factor for atherosclerosis (AS) and neurodegenerative diseases like Alzheimer's disease (AD), but whether and how APOE4 induces AD‐like neuropathies in the brain of AS pathology remains poorly characterized.
Methods
By combining postmortem AS human brains and APOE4 knock‐in mice, we examined the effects of APOE4 on tau and related neuropathological changes in the brain of AS. Behavioral and pathological observations were used to evaluate the protective effects of facilitating cholesterol transport in APOE4 AS mice.
Results
Here, we showed that APOE4 carriers exhibited higher AD‐like phosphorylated Tau (p‐Tau) levels in AS postmortem brains. Knocking in human APOE4 in high fat diet‐fed mice induced AS pathology and coupled AS and AD. APOE4 promoted cerebral cholesterol content, which could trigger protein phosphatase 2A (PP2A) degradation. We further demonstrated cholesterol could facilitate the ubiquitination of PP2A B and PP2A C, which were regulatory and catalytic subunits of PP2A respectively, leading to PP2A B and PP2A C degradation through the ubiquitin‐proteasome system. Reduced PP2A B and PP2A C resulted in cerebral Tau hyperphosphorylated at multiple AD‐associated sites. The APOE4 AS mice exhibited an AD‐like phenotype, including synaptic degeneration, blood‐brain barrier breakdown, glial activation, and cognitive impairment simultaneously. Pharmacologically facilitating cholesterol transport alleviated neuropathologies in APOE4 AS mice.
Conclusion
Altogether, these results suggested a role of the APOE4 in linking AS with Tau neuropathology, which might increase the risk of related neurodegenerative diseases for AS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Forensic Medicine, Guizhou Medical University, Guiyang, China.
- Key Laboratory of Human Brain Bank for Functions and Diseases of Department of Education of Guizhou Province, Guizhou Medical University, Guiyang, China.
- Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, China.
- Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
- Guangzhou Key Laboratory of Forensic Multi-Omics for Precision Identification, School of Forensic Medicine, Southern Medical University, Guangzhou, China.
- Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, Peking University, Beijing, China.
ORCID-Profile: Jiuyang Ding, Yang Gao
Förderung
- Department of Education of Guizhou Province
- Guizhou Provincial Science and Technology Projects
- Science Innovation 2030 - Brain Science and Brain-Inspired Intelligence Technology Major Project
- National Natural Science Foundation of China
- Guizhou Provincial Science and Technology Program Project Grant
- Guizhou Provincial Basic Research Program (Natural Science)
- Guizhou Provincial Education Department Young Scientific Talent
Zitieren
APA
Ding, J., Sun, B., Gao, Y., Gu, C., Zhang, J., Wang, L., Zheng, J., Xia, B., & Qi, X. (2025). APOE4 Exacerbates Cerebral Tau Pathology Through Cholesterol‐Induced Degradation of Phosphatase in Atherosclerosis. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70536
Vancouver
Ding J, Sun B, Gao Y, Gu C, Zhang J, Wang L, et al. APOE4 Exacerbates Cerebral Tau Pathology Through Cholesterol‐Induced Degradation of Phosphatase in Atherosclerosis. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70536
BibTeX
@article{Ding2025,
author = {Ding, Jiuyang and Sun, Baofei and Gao, Yang and Gu, Cihang and Zhang, Jian and Wang, Li and Zheng, Jie and Xia, Bing and Qi, Xiaolan},
title = {APOE4 Exacerbates Cerebral Tau Pathology Through Cholesterol‐Induced Degradation of Phosphatase in Atherosclerosis},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70536}
}
EUVIMED